Monday, February 24, 2025 at 12:30 pm US EST
The traditional analytical life cycle for quality control of drugs fits not well with the N-of-1-treatments as it requests laborious qualifications/validations to show that the analytical procedure is fit-for-purpose. In the seminar we discuss the traditional analytical life cycle and possibilities/challenges to adapt it to N-of-1-treatments.
Christoph R. Grünig, PhD, gained his PhD at the Swiss Federal Institute of Technology (ETH), Zürich studying the taxonomy and genetics of fungal plant pathogens. He works at Microsynth since 2010, and gained in-depth knowledge in DNA/RNA based analytics over a broad range of analytical platforms. Christoph is involved in the development, qualification and validation of DNA/RNA based analytical procedures in the field of gene/cell therapy as well as mRNA vaccines covering pre-clinical studies, clinical trials and marketed drugs.
تعليقات